{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T12:59:36Z","timestamp":1791464376926,"version":"4.3.4"},"reference-count":54,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["64302"],"award-info":[{"award-number":["64302"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajog.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Obstetrics and Gynecology"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.ajog.2022.05.043","type":"journal-article","created":{"date-parts":[[2022,5,26]],"date-time":"2022-05-26T22:03:15Z","timestamp":1653602595000},"page":"618.e1-618.e16","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":58,"title":["Diagnostic utility of serial circulating placental growth factor levels and uterine artery Doppler waveforms in diagnosing underlying placental diseases in pregnancies at high risk of placental dysfunction"],"prefix":"10.1016","volume":"227","author":[{"given":"Swati","family":"Agrawal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W. Tony","family":"Parks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen Dehui","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anjana","family":"Ravichandran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eran","family":"Ashwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rory C.","family":"Windrim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian R.","family":"Hobson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nir","family":"Melamed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7411-5535","authenticated-orcid":false,"given":"John C.","family":"Kingdom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajog.2022.05.043_bib1","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.ajog.2010.08.009","article-title":"The \u201cGreat Obstetrical Syndromes\u201d are associated with disorders of deep placentation","volume":"204","author":"Brosens","year":"2011","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2022.05.043_bib2","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1067\/mob.2002.126866","article-title":"Punch biopsy of the human placental bed","volume":"187","author":"Robson","year":"2002","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2022.05.043_bib3","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.ogc.2019.10.008","article-title":"The placental basis of fetal growth restriction","volume":"47","author":"Zur","year":"2020","journal-title":"Obstet Gynecol Clin North Am"},{"key":"10.1016\/j.ajog.2022.05.043_bib4","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1161\/HYPERTENSIONAHA.120.14701","article-title":"T2\u2217 placental magnetic resonance imaging in preterm preeclampsia: an observational cohort study","volume":"75","author":"Ho","year":"2020","journal-title":"Hypertension"},{"key":"10.1016\/j.ajog.2022.05.043_bib5","doi-asserted-by":"crossref","first-page":"S1145","DOI":"10.1016\/j.ajog.2021.08.027","article-title":"Circulating maternal placental growth factor responses to low-molecular-weight heparin in pregnant patients at risk of placental dysfunction","volume":"226","author":"McLaughlin","year":"2022","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2022.05.043_bib6","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1161\/CIRCULATIONAHA.113.003215","article-title":"Diagnostic accuracy of placental growth factor in women with suspected preeclampsia: a prospective multicenter study","volume":"128","author":"Chappell","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.ajog.2022.05.043_bib7","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1161\/HYPERTENSIONAHA.119.13360","article-title":"Predictive performance of PlGF (placental growth factor) for screening preeclampsia in asymptomatic women: a systematic review and meta-analysis","volume":"74","author":"Agrawal","year":"2019","journal-title":"Hypertension"},{"key":"10.1016\/j.ajog.2022.05.043_bib8","doi-asserted-by":"crossref","first-page":"629.e1","DOI":"10.1016\/j.ajog.2015.11.015","article-title":"Maternal plasma angiogenic index-1 (placental growth factor\/soluble vascular endothelial growth factor receptor-1) is a biomarker for the burden of placental lesions consistent with uteroplacental underperfusion: a longitudinal case-cohort study","volume":"214","author":"Korzeniewski","year":"2016","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2022.05.043_bib9","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1161\/HYPERTENSIONAHA.121.17047","article-title":"PlGF (placental growth factor) testing in clinical practice: evidence from a Canadian tertiary maternity referral center","volume":"77","author":"McLaughlin","year":"2021","journal-title":"Hypertension"},{"key":"10.1016\/j.ajog.2022.05.043_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.placenta.2016.03.010","article-title":"Placental growth factor as a marker of fetal growth restriction caused by placental dysfunction","volume":"42","author":"Benton","year":"2016","journal-title":"Placenta"},{"key":"10.1016\/j.ajog.2022.05.043_bib11","first-page":"451","article-title":"Placental pathology in relation to uterine artery Doppler findings in pregnancies with severe intrauterine growth restriction and abnormal umbilical artery Doppler changes","volume":"34","author":"Levytska","year":"2017","journal-title":"Am J Perinatol"},{"key":"10.1016\/j.ajog.2022.05.043_bib12","doi-asserted-by":"crossref","first-page":"S803","DOI":"10.1016\/j.ajog.2017.11.575","article-title":"A\u00a0placenta clinic approach to the diagnosis and management of fetal growth restriction","volume":"218","author":"Kingdom","year":"2018","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2022.05.043_bib13","doi-asserted-by":"crossref","first-page":"326.e1","DOI":"10.1016\/j.ajog.2006.11.002","article-title":"Identification of patients at risk for early onset and\/or severe preeclampsia with the use of uterine artery Doppler velocimetry and placental growth factor","volume":"196","author":"Espinoza","year":"2007","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2022.05.043_bib14","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1111\/1471-0528.12195","article-title":"Angiogenic factors combined with clinical risk factors to predict preterm pre-eclampsia in nulliparous women: a predictive test accuracy study","volume":"120","author":"Myers","year":"2013","journal-title":"BJOG"},{"key":"10.1016\/j.ajog.2022.05.043_bib15","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1056\/NEJMoa1704559","article-title":"Aspirin versus placebo in pregnancies at high risk for preterm preeclampsia","volume":"377","author":"Rolnik","year":"2017","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ajog.2022.05.043_bib16","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1002\/uog.17494","article-title":"Placental histopathology associated with pre-eclampsia: systematic review and meta-analysis","volume":"50","author":"Falco","year":"2017","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.ajog.2022.05.043_bib17","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.placenta.2018.09.002","article-title":"The role of placental malperfusion in the pathogenesis of preeclampsia in dichorionic twin and\u00a0singleton pregnancies","volume":"70","author":"Aviram","year":"2018","journal-title":"Placenta"},{"key":"10.1016\/j.ajog.2022.05.043_bib18","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.placenta.2021.12.008","article-title":"Research priority setting partnership for placental pathology","volume":"117","author":"Khong","year":"2022","journal-title":"Placenta"},{"key":"10.1016\/j.ajog.2022.05.043_bib19","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1016\/j.ajog.2015.05.056","article-title":"Classification of placental lesions","volume":"213","author":"Redline","year":"2015","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2022.05.043_bib20","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.placenta.2010.11.021","article-title":"Chronic histiocytic intervillositis of unknown etiology: clinical features in a consecutive series of 69 cases","volume":"32","author":"Marchaudon","year":"2011","journal-title":"Placenta"},{"key":"10.1016\/j.ajog.2022.05.043_bib21","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.placenta.2019.12.020","article-title":"Is chronic histiocytic intervillositis a severe placental disease? A case-control study","volume":"91","author":"Homatter","year":"2020","journal-title":"Placenta"},{"key":"10.1016\/j.ajog.2022.05.043_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.placenta.2018.02.002","article-title":"Chronic histiocytic intervillositis \u2013 clinical, biochemical and radiological findings: an observational study","volume":"64","author":"Koby","year":"2018","journal-title":"Placenta"},{"key":"10.1016\/j.ajog.2022.05.043_bib23","doi-asserted-by":"crossref","first-page":"855","DOI":"10.3109\/14767058.2015.1022864","article-title":"Pravastatin to prevent recurrent fetal death in massive perivillous fibrin deposition of the placenta (MPFD)","volume":"29","author":"Chaiworapongsa","year":"2016","journal-title":"J\u00a0Matern Fetal Neonatal Med"},{"key":"10.1016\/j.ajog.2022.05.043_bib24","article-title":"Immunomodulatory therapy reduces the severity of placental lesions in chronic histiocytic intervillositis","volume":"8","author":"Brady","year":"2021","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.ajog.2022.05.043_bib25","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1002\/uog.23698","article-title":"ISUOG Practice Guidelines (updated): use of Doppler velocimetry in obstetrics","volume":"58","author":"Bhide","year":"2021","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.ajog.2022.05.043_bib26","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.ajog.2021.11.1357","article-title":"Clinical Opinion: the diagnosis and management of suspected fetal growth restriction: an evidence-based approach","volume":"226","author":"Lees","year":"2022","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2022.05.043_bib27","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1002\/uog.5315","article-title":"Reference ranges for uterine artery mean pulsatility index at 11-41 weeks of gestation","volume":"32","author":"G\u00f3mez","year":"2008","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.ajog.2022.05.043_bib28","first-page":"1122","article-title":"Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists\u2019 Task Force on Hypertension in Pregnancy","volume":"122","year":"2013","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2022.05.043_bib29","doi-asserted-by":"crossref","first-page":"E35","DOI":"10.1542\/peds.108.2.e35","article-title":"A\u00a0new and improved population-based Canadian reference for birth weight for gestational age","volume":"108","author":"Kramer","year":"2001","journal-title":"Pediatrics"},{"key":"10.1016\/j.ajog.2022.05.043_bib30","doi-asserted-by":"crossref","first-page":"698","DOI":"10.5858\/arpa.2015-0225-CC","article-title":"Sampling and definitions of placental lesions: Amsterdam placental workshop group consensus statement","volume":"140","author":"Khong","year":"2016","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.ajog.2022.05.043_bib31","doi-asserted-by":"crossref","first-page":"372","DOI":"10.5858\/arpa.2020-0753-OA","article-title":"Interobserver reliability for identifying specific patterns of placental injury as defined by the Amsterdam classification","volume":"146","author":"Redline","year":"2022","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.ajog.2022.05.043_bib32","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1007\/s00404-020-05546-x","article-title":"Placental pathology in pregnancies complicated by fetal growth restriction: recurrence vs. new onset","volume":"301","author":"Levy","year":"2020","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.ajog.2022.05.043_bib33","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.preghy.2019.09.021","article-title":"Pregnancy outcomes in correlation with placental histopathology in subsequent pregnancies complicated by preeclampsia","volume":"18","author":"Levy","year":"2019","journal-title":"Preg Hypertens"},{"key":"10.1016\/j.ajog.2022.05.043_bib34","doi-asserted-by":"crossref","first-page":"2901","DOI":"10.1093\/cercor\/bhx167","article-title":"fMRI-based neuronal response to new odorants in the newborn brain","volume":"28","author":"Adam-Darque","year":"2018","journal-title":"Cereb Cortex"},{"key":"10.1016\/j.ajog.2022.05.043_bib35","first-page":"B2","article-title":"Electronic address: pubs@smfm.org, Martins JG, Biggio JR, Abuhamad A. Society for Maternal-Fetal Medicine Consult Series #52: diagnosis and management of fetal growth restriction: (replaces Clinical Guideline Number 3, April 2012)","volume":"223","year":"2020","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2022.05.043_bib36","doi-asserted-by":"crossref","first-page":"594.e1","DOI":"10.1016\/j.ajog.2017.06.013","article-title":"Role of early second-trimester uterine artery Doppler screening to predict small-for-gestational-age babies in nulliparous women","volume":"217","author":"Parry","year":"2017","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2022.05.043_bib37","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1002\/uog.22134","article-title":"ISUOG Practice Guidelines: diagnosis and management of small-for-gestational-age fetus and fetal growth restriction","volume":"56","author":"Lees","year":"2020","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.ajog.2022.05.043_bib38","doi-asserted-by":"crossref","first-page":"S786","DOI":"10.1016\/j.ajog.2021.12.001","article-title":"Preeclampsia and eclampsia: the conceptual evolution of a syndrome","volume":"226","author":"Erez","year":"2022","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2022.05.043_bib39","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1056\/NEJMoa1414838","article-title":"Predictive value of the sFlt-1:PlGF ratio in women with suspected preeclampsia","volume":"374","author":"Zeisler","year":"2016","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ajog.2022.05.043_bib40","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1161\/CIRCULATIONAHA.111.054361","article-title":"Angiogenic factors and the risk of adverse outcomes in women with suspected preeclampsia","volume":"125","author":"Rana","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.ajog.2022.05.043_bib41","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1097\/AOG.0000000000004149","article-title":"Biomarkers and the prediction of adverse outcomes in preeclampsia: a systematic review and meta-analysis","volume":"137","author":"Lim","year":"2021","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2022.05.043_bib42","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1161\/HYPERTENSIONAHA.117.10182","article-title":"Meta-analysis and systematic review to assess the role of soluble FMS-like tyrosine kinase-1 and placenta growth factor ratio in prediction of preeclampsia: the SaPPPhirE study","volume":"71","author":"Agrawal","year":"2018","journal-title":"Hypertension"},{"key":"10.1016\/j.ajog.2022.05.043_bib43","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1038\/s41591-020-0804-9","article-title":"A\u00a0maternal serum metabolite ratio predicts fetal growth restriction at term","volume":"26","author":"Sovio","year":"2020","journal-title":"Nat Med"},{"key":"10.1016\/j.ajog.2022.05.043_bib44","doi-asserted-by":"crossref","first-page":"163.e1","DOI":"10.1016\/j.ajog.2011.09.019","article-title":"Can placental growth factor in maternal circulation identify fetuses with placental intrauterine growth restriction?","volume":"206","author":"Benton","year":"2012","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2022.05.043_bib45","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/ajo.12831","article-title":"Placental growth factor as an indicator of fetal growth restriction in late-onset small-for-gestational age pregnancies","volume":"59","author":"Anderson","year":"2019","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"10.1016\/j.ajog.2022.05.043_bib46","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1161\/HYPERTENSIONAHA.119.13763","article-title":"Combining biomarkers to predict pregnancy complications and redefine preeclampsia: the angiogenic-placental syndrome","volume":"75","author":"Stepan","year":"2020","journal-title":"Hypertension"},{"key":"10.1016\/j.ajog.2022.05.043_bib47","doi-asserted-by":"crossref","first-page":"310.e1","DOI":"10.1016\/j.ajog.2013.01.017","article-title":"Evidence of an imbalance of angiogenic\/antiangiogenic factors in massive perivillous fibrin deposition (maternal floor infarction): a placental lesion associated with recurrent miscarriage and fetal death","volume":"208","author":"Whitten","year":"2013","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2022.05.043_bib48","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1016\/j.jogc.2021.01.018","article-title":"Second trimester placental growth factor levels and placental histopathology in low-risk nulliparous pregnancies","volume":"43","author":"Audette","year":"2021","journal-title":"J\u00a0Obstet Gynaecol Can"},{"key":"10.1016\/j.ajog.2022.05.043_bib49","doi-asserted-by":"crossref","first-page":"5887","DOI":"10.1038\/s41598-017-06178-z","article-title":"Endothelial dysfunction in severe preeclampsia is mediated by soluble factors, rather than extracellular vesicles","volume":"7","author":"O\u2019Brien","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.ajog.2022.05.043_bib50","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/j.humpath.2010.11.018","article-title":"Placental expression of vascular endothelial growth factor receptor-1\/soluble vascular endothelial growth factor receptor-1 correlates with severity of clinical preeclampsia and villous hypermaturity","volume":"42","author":"Tach\u00e9","year":"2011","journal-title":"Hum Pathol"},{"key":"10.1016\/j.ajog.2022.05.043_bib51","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1056\/NEJMoa031884","article-title":"Circulating angiogenic factors and the risk of preeclampsia","volume":"350","author":"Levine","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajog.2022.05.043_bib52","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1111\/apm.12796","article-title":"Placental pathologic lesions with a significant recurrence risk \u2013 what not to miss!","volume":"126","author":"Chen","year":"2018","journal-title":"APMIS"},{"key":"10.1016\/j.ajog.2022.05.043_bib53","doi-asserted-by":"crossref","first-page":"n2103","DOI":"10.1136\/bmj.n2103","article-title":"Use of metformin to prolong gestation in preterm pre-eclampsia: randomised, double blind, placebo controlled trial","volume":"374","author":"Cluver","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.ajog.2022.05.043_bib54","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.placenta.2021.12.013","article-title":"Massive perivillous fibrin deposition of the placenta and pregnancy outcome: a retrospective observational study","volume":"117","author":"Lampi","year":"2022","journal-title":"Placenta"}],"container-title":["American Journal of Obstetrics and Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937822003945?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937822003945?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T11:39:34Z","timestamp":1757590774000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002937822003945"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":54,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["S0002937822003945"],"URL":"https:\/\/doi.org\/10.1016\/j.ajog.2022.05.043","relation":{},"ISSN":["0002-9378"],"issn-type":[{"value":"0002-9378","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diagnostic utility of serial circulating placental growth factor levels and uterine artery Doppler waveforms in diagnosing underlying placental diseases in pregnancies at high risk of placental dysfunction","name":"articletitle","label":"Article Title"},{"value":"American Journal of Obstetrics and Gynecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajog.2022.05.043","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}